Search for: "Teva USA" Results 201 - 220 of 713
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 May 2017, 8:26 am by Eric Caligiuri
(“Helsinn”) brought suit against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. [read post]
4 May 2017, 8:26 am by Eric Caligiuri
(“Helsinn”) brought suit against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. [read post]
20 Oct 2008, 3:34 am
., USA et al. v. [read post]
11 Dec 2017, 5:16 pm by Aurora Barnes
The petition of the day is: Teva Pharmaceuticals USA, Inc. v. [read post]
6 Oct 2008, 3:38 am
Teva Pharmaceuticals USA Inc.1:08-cv-00627; filed September 26, 2009 in the District Court of Delaware Infringement of U.S. [read post]
26 Jan 2015, 10:37 am by Dennis Crouch
The Judgments are vacated, and the cases are remanded to the United States Court of Appeals for the Federal Circuit for further consideration in light of Teva Pharmaceuticals USA, Inc., v. [read post]
4 Dec 2018, 6:24 am by Robert Kraft
USA Today reported Teva Pharmaceuticals issued the voluntary recall for “all lots of combination tablets featuring the drugs amlodipine and valsartan and another combo drug featuring amlodipine, valsartan, and hydrochlorothiazide. [read post]
14 Feb 2022, 9:38 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 18-1976 (Fed. [read post]
15 Apr 2019, 9:23 pm by Patent Docs
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc.... [read post]
16 May 2019, 8:15 am by Robert Schaffer & Joseph Robinson
The Federal Circuit recently affirmed a district court ruling finding patent infringement after holding that Actavis LLC, Actavis South Atlantic LLC, and Teva Pharmaceuticals USA, Inc. [read post]
25 May 2017, 6:20 pm by Lawrence B. Ebert
A post concerning future generic "Copaxone" at raps.org beginsGeneric versions of Teva's multi-billion-dollar per year multiple sclerosis drug Copaxone (glatiramer) are coming, but a closer look at which competitor might win the coveted 180-day exclusivity for its generic reveals an unusual and complex situation.Back in January, a US District Court for the District of Delaware ruling invalidated all asserted claims on Teva's patents on its 40mg version of… [read post]
11 Sep 2014, 6:08 am
A pain medication known as Darvocet has been on the market since 1972, when it first received approval from the U.S. [read post]
1 Apr 2014, 4:52 am by Amy Howe
  This blog’s Lyle Denniston covered the certiorari grant in Teva Pharmaceuticals USA v. [read post]
19 Nov 2016, 4:48 am by Gregory B. Williams
Teva Pharmaceuticals USA, Inc., Civil Action No. 14-874-SLR (D.Del., November 16, 2016), the Court found the asserted claims of U.S. [read post]
17 Jan 2012, 12:18 pm by Dennis Crouch
Gomez is a Patent Agent at Teva Pharmaceuticals USA. [read post]